|
Re: Managing the message
|
7
|
Resverlogix Corp.
|
Jun 08, 2016 10:22AM
|
|
Re: Management
|
9
|
Resverlogix Corp.
|
Apr 06, 2021 10:33AM
|
|
Re: Management
|
11
|
Resverlogix Corp.
|
Apr 05, 2021 03:31PM
|
|
Re: Lower highs, lower lows...
|
|
Resverlogix Corp.
|
Jan 04, 2018 04:13PM
|
|
Re: Lower highs, lower lows...
|
|
Resverlogix Corp.
|
Jan 04, 2018 07:50PM
|
|
Re: Looks like 0 participation in warrant incentive imo - answer to my email...
|
6
|
Resverlogix Corp.
|
Jan 16, 2020 01:45PM
|
|
Re: Looking over Amarin does lead to one obvious conclusion...
|
2
|
Resverlogix Corp.
|
Feb 14, 2019 02:00PM
|
|
Re: Long-covid still has no cure
|
9
|
Resverlogix Corp.
|
Apr 03, 2024 03:04PM
|
|
Re: Long Covid
|
4
|
Resverlogix Corp.
|
Jan 19, 2024 05:38PM
|
|
Re: Loan, Renal, Fabry's
|
4
|
Resverlogix Corp.
|
Aug 29, 2017 09:20AM
|
|
Re: Liquidity
|
4
|
Zenith Epigenetics
|
Jan 22, 2016 06:36PM
|
|
Re: Liquidity
|
5
|
Zenith Epigenetics
|
Jan 24, 2016 12:49PM
|
|
Re: Liquidity
|
5
|
Zenith Epigenetics
|
Aug 02, 2019 01:54AM
|
|
Re: Lilly to Discontinue Development of Evacetrapib
|
6
|
Resverlogix Corp.
|
Oct 12, 2015 04:22PM
|
|
Re: Lilly alzheimer drug failed
|
5
|
Resverlogix Corp.
|
Nov 24, 2016 12:29PM
|
|
Re: Licensing Deal
|
3
|
Resverlogix Corp.
|
Feb 27, 2017 07:51PM
|
|
Re: Let's play a what if...
|
5
|
Resverlogix Corp.
|
Nov 27, 2019 03:28PM
|
|
Re: Leading From Behind
|
7
|
Resverlogix Corp.
|
Oct 14, 2020 10:28AM
|
|
Re: Last day of June.
|
11
|
Resverlogix Corp.
|
Jul 02, 2021 11:15AM
|
|
Re: Language is very important....
|
3
|
Resverlogix Corp.
|
Sep 09, 2016 07:45PM
|
